Lung infection monitor for chronic disease patients

慢性病患者肺部感染监测

• 批准号: 102423
• 金额: $ 84.01万
• 依托单位: OHMEDICS LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2015
• 资助国家: 英国
• 起止时间: 2015 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=102423
• 关键词: Lung; infection; monitor; chronic; disease

Bacterial and fungal lung infections are one of the biggest causes of death worldwide. People whosuffer from chronic lung diseases such as chronic obstructive pulmonary disease, bronchiectasis or cysticfibrosis, are more susceptible to lung infections. These infections make their condition much worse,decreasing patient quality of life and increasing healthcare costs. We are developing a device that canbe used by patients at home to monitor daily for lung infections caused by pathogenic bacteria andfungi. By identifying infections early, lung damage will be minimised and patient quality of lifeimproved. Additionally, the infection monitor will be usable by doctors in a GP surgery or clinic todiagnose a suspected bacterial or fungal infection in patients. This will help reduce the unnecessaryprescription of antibiotics where instead of having a beneficial effect they cause an increase in antimicrobial resistance, one of biggest future threats facing healthcare.

细菌和真菌肺部感染是全球最大的死亡原因之一。患有慢性肺病如慢性阻塞性肺病、支气管扩张或囊性纤维化的人更容易受到肺部感染。这些感染使他们的病情更加恶化，降低了患者的生活质量，增加了医疗费用。我们正在开发一种设备，病人可以在家里使用，每天监测由病原菌和真菌引起的肺部感染。通过早期发现感染，肺损伤将最小化，患者的生活质量将得到改善。此外，感染监测器将可用于医生在全科医生手术或诊所诊断可疑的细菌或真菌感染的病人。这将有助于减少抗生素的不必要处方，而不是产生有益的效果，它们会导致抗菌素耐药性的增加，这是医疗保健面临的最大未来威胁之一。